Previous studies offer a limited perspective on the dynamic course of distress in cancer patients and their partners, owing to a restricted number of assessment points and the absence of comparison controls drawn from the general population. This study investigated the course of distress among breast cancer patients and their partners (N = 92 couples) in comparison to matched control couples (N = 64). Furthermore, the influence of neuroticism on distress was investigated. The Hospital Anxiety and Depression Scale was administered nine times over a 12-month period, and neuroticism was assessed at the beginning of the study using the Eysenck Personality Questionnaire. Multilevel analyses revealed that patients were more distressed during the first 15 months after diagnosis than nonpatients. A significant portion of the distress that could not be explained by the cancer experience was explained by neuroticism. Differences in distress between patients and comparison-control women are relatively small and decreased over time, while distress in male partners was not elevated in comparison to their controls.
Background: Patients need cognitive and social skills in order to be able to make informed healthcare decisions. Health literacy (HL) encompasses these skills, enabling individuals to manage their conditions and adapt to challenges. HL interventions in patients could be a powerful way of optimizing self-management (SM) in individuals with chronic diseases. Purpose: To examine the efficacy of HL interventions on the medical, emotional, and role management domains of SM, theoretical foundations, conceptualizations of HL and SM, and intervention components. Methods: Health literacy interventions aimed at increasing SM in adults (≥18 years) with chronic diseases were considered. A database search was conducted in PubMed, Scopus, SciELO (Scientific Electronic Library Online), and Web of Science from 2014 to 2024. Results were reported according to the Preferred Reporting Items for Systematic Reviews and Meta-analyses. Risk of bias was assessed using the Joanna Briggs Institute Checklist. Results: Fourteen studies were included. Interventions improved 3 components of medical management: medication adherence, disease knowledge, and self-efficacy. However, the effects on adherence to diet and exercise regimens, also part of medical management, were inconclusive. Emotional and role management received limited attention. There was inconsistency between HL definitions and instruments. Most interventions were delivered through in-person sessions. Overall, studies showed moderate risk of bias, which may have influenced the results. Conclusions: Theory-based interventions, methodological consistency, and comprehensive HL and SM measures are needed to understand interventions’ effectiveness. To support behavioral change, HL interventions must address emotional and role management. Future high-quality research is required to determine optimal strategies for strengthening SM through HL interventions.
1 January 2004 in The American Journal of Geriatric Psychiatry
Pharmacogenomics (PGx) can provide optimized treatment to individual patients while potentially reducing healthcare costs. However, widespread implementation remains absent. We performed a pilot study of PGx screening in Dutch outpatient hospital care to identify the barriers and facilitators to implementation experienced by patients (n = 165), pharmacists (n = 58) and physicians (n = 21). Our results indeed suggest that the current practical experience of healthcare practitioners with PGx is limited, that proper education is necessary, that patients want to know the exact implications of the results, that healthcare practitioners heavily rely on their computer systems, that healthcare practitioners encounter practical problems in the systems used, and a new barrier was identified, namely that there is an unclear allocation of responsibilities between healthcare practitioners about who should discuss PGx with patients and apply PGx results in healthcare. We observed a positive attitude toward PGx among all the stakeholders in our study, and among patients, this was independent of the occurrence of drug-gene interactions during their treatment. Facilitators included the availability of and adherence to Dutch Pharmacogenetics Working Group guidelines. While clinical decision support (CDS) is available and valued in our medical center, the lack of availability of CDS may be an important barrier within Dutch healthcare in general.